Hospira GemStar Infusion pump 의 리콜

New Zealand Medicines and Medical Devices Safety Authority에 따르면, 해당 리콜 는 New Zealand 에서 Hospira Inc 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    15684
  • 사례 시작날짜
    2013-11-22
  • 사례 국가
  • 사례 출처
    NZMMDSA
  • 사례 출처 URL
  • 비고 / 경고
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • 데이터 추가 비고
    Recalling Organisation: Hospira NZ Ltd, 58 Richard Pearse Drive, Airport Oaks, Mangere, Auckland 2022
  • 원인
    Hospira has become aware that some healthcare professionals may not have appropriately secured their gemstar infusion pumps via the keypad lock code. reports indicate that patients or unauthorized carers have been able to locate the default keypad lock code for gemstar infusion pumps through internet searches in order to tamper with programmed infusion parameters. one of the reports resulted in a serious injury, hospira have received no reports relating to this issue in new zealand or australia.
  • 조치
    Instructions for use to be updated

Device

  • 모델명 / 제조번호(시리얼번호)
    Model: List numbers: 13000, 13087, 13088, 13150, 13100, Affected: All serial numbers
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    NZMMDSA